X. An Example We review the guidelines recommended to this
point through an example. We consider a car-
diovascular disease study involving the 9-year
follow-up of persons from Evans County, Geor-
gia. We focus on data involving 609 white
males on which we have measured six vari-
ables at the start of the study. These are cate-
cholamine level (CAT), AGE, cholesterol level
(CHL), smoking status (SMK), electrocardio-
gram abnormality status (ECG), and hyperten-
sion status (HPT). The outcome variable is
coronary heart disease status (CHD).
In this study, the exposure variable is CAT,
which is 1 if high and 0 if low. The other five
variables are control variables, so that these
may be considered as confounders and/or
effect modifiers. AGE and CHL are treated con-
tinuously, whereas SMK, ECG, and HPT, are
(0, 1) variables.
The question of interest is to describe the
relationship betweenE(CAT) andD(CHD),
controlling for the possible confounding and
effect-modifying effects of AGE, CHL, SMK,
ECG, and HPT. These latter five variables are
theCs that we have specified at the start of our
modeling strategy.
To follow our strategy for dealing with this
data set, we now carry out variable specifica-
tion in order to define the initial model to be
considered. We begin by specifying theVvari-
ables, which represent the potential confoun-
ders in the initial model.
In choosing theVs, we follow our earlier re-
commendation to let theVs be the same as
theCs. Thus, we will letV 1 ¼AGE,V 2 ¼CHL,
V 3 ¼SMK,V 4 ¼ECG, andV 5 ¼HPT.
We could have chosen otherVs in addition to the
fiveCs. For example, we could have considered
Vs that are products of twoCs, such asV 6 equals
AGECHL orV 7 equals AGESMK. We could
also have consideredVsthataresquaredCs,
such asV 8 equals AGE^2 orV 9 equals CHL^2.
EXAMPLE
Cardiovascular Disease Study
9-year follow-up Evans County, GA
n¼609 white males
The variables:
CAT|fflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl{zfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl};AGE;CHL;SMK;ECG;HPT
at start
CHD¼outcome
CAT: (0, 1) exposure
AGE;CHL:continuous
SMK;ECG;HPT:ð 0 ; 1 Þ
)
control
variables
E¼CAT? D¼CHD
controlling for
AGE|fflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl{zfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl};CHL;SMK;ECG;HPT
Cs
Variable specification stage:
Vs: potential confounders in initial
model
Here,Vs¼Cs:
V 1 ¼AGE;V 2 ¼CHL;V 3 ¼SMK;
V 4 ¼ECG;V 5 ¼HPT
Other possibleVs:
V 6 ¼AGECHL
V 7 ¼AGESMK
V 8 ¼AGE^2
V 9 ¼CHL^2
188 6. Modeling Strategy Guidelines